Carmignac Gestion Increases Stake in Regeneron Pharmaceuticals, Inc. (REGN) by 133.3%
Filing Details Carmignac Gestion, a registered investment adviser, increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 133.3% during Q1 2026, according to…
Read more
